Our story

Alvéole was founded in 2010 by three researchers from CNRS1-2-3 in collaboration with Quattrocento, a “creator of young innovative companies” in the life sciences field that allows academic researchers to transform their inventions into commercial products.

Vincent Studer (a specialist in bio-engineering), Maxime Dahan (a specialist in cell imaging), and Jean-Christophe Galas (a specialist in nanostructures) have collaborated since 2008 to develop tools for research in cell biology. In 2010, Quattrocento founded Alvéole, with their collaboration.

1Vincent Studer, the Neurosciences Interdisciplinary Institute (CNRS, University of Bordeaux).
2 Maxime Dahan, the Curie Physics and Chemistry Unit, (CNRS, Curie Institute, Pierre and Marie Curie University).
3Jean-Christophe Galas, the Jean Perrin Laboratory, (CNRS, Pierre and Marie Curie University).

Alvéole’s R&D and academic partnerships

Alvéole’s research, development and industrialization experts use the latest innovations in cell imaging, chemistry and biology.

Since it was founded, Alvéole has concluded solid and sustainable academic partnerships, to become a leading player in technology. The goal of these partnerships is to push PRIMO forward, so it will become a standard tool in cellular biology. They are headed by internationally recognized experts who are PRIMO’s ambassadors.

Your needs,
Our innovations

Our team’s constant concern is daily interactions, so we can always consider developments from the angle of user needs.

A large share of Alvéole’s activities target the understanding and assessment of what research teams need to improve the existing technological platform and hone fresh solutions.

Our vision

Alvéole’s goal is to become the reference for tools for creating in vitro biomimetic cellular environments.

Since 2010 and the knowledge that the microenvironment controls cells, biology research experts have required new tools.

This is why Alvéole’s team created PRIMO:  a bioengineering platform performing structuration (by photopolymerization) and biofunctionalization (by protein micropatterning) of cell culture substrates.

This innovative technology makes it possible to create tailored environments in the laboratory where cells (including induced stem cells) can behave as they do in the body and therefore be studied more reliably.

PRIMO thus accelerates scientific research while reducing the use of animal models and opens up new possibilities for tests that are more standardized for developing new pharmacological drugs.

Award-winning projects

SLAS: PRIMO elected best 2016 product

SLAS: PRIMO elected best 2016 product

SLAS (Society for Laboratory Automation and Screening) is a worldwide community with over 30,000 university and industrial scientists who all target the optimization that potential technologies have in the progress of research work. There were 320 exhibitors in the 2016 edition of the SLAS conference that took place in San Diego. During this event, new products were assessed for their innovative advantages and impacts in the field of laboratory techniques. PRIMO was chosen as the best product in 2016.

The Paris Grands Prix de l’Innovation (Innovation Trophies): 2017 Finalist

The Paris Grands Prix de l’Innovation (Innovation Trophies): 2017 Finalist

Alvéole was selected as a finalist in the Health section of the City of Paris Innovation Trophies. The goal of this contest is to support and reward innovative Parisian companies in quickly growing fields, which develop the economy in Greater Paris. Since it was founded, the Innovation Trophies have awarded 67 prizes to over 3,200 candidates. The 2017 Awards Ceremony will be held on December 12 in Paris.

The 2014 Worldwide Innovation Contest: Alvéole comes in first place

The 2014 Worldwide Innovation Contest: Alvéole comes in first place

Alvéole was the winner of the Worldwide Innovation Contest for its CellForLife project in the individual medicine category. This ambitious project proposes a complete offer with a manipulation platform and a miniaturized device to control stem cell differentiation, in order to devise personalized treatments for patients suffering from genetic diseases. In the framework of their work on Rett syndrome, researchers from the Cochin Institute used tools made by Alvéole to understand this pathology and develop targeted therapies.

Meet our team

Working together on a daily basis with a common vision, the multidisciplinary skills of Alvéole’s team are in line with users’ needs (chemistry, material physics, cell biology).
LEARN MORE

Our partners

In order to become a sustainable player in its market, since 2016 Alvéole has been building a network of industrial, commercial and academic partnerships with companies and laboratories with recognized international expertise.
LEARN MORE